Silver sodium nitroprusside nano-aggregates for ultrasound-activated immunomodulatory therapy of MRSA pneumonia
Biomedical Materials · 2026
DOI: 10.1088/1748-605x/aeb215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, 2026. Verfasst von Minxian Ji und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Examination, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou 510280, People's Repub…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Nitroprusside, Silver, Metal Nanoparticles. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Key Laboratory of Polymeric Composite and Functional Materials of Ministry of Education, GuangDong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
The clinical management of methicillin-resistant S. aureus (MRSA) pneumonia is hindered by biofilm infections and cytokine storms. A key challenge is the lack of real-time monitoring tools for the inflammatory microenvironment during treatment. In this study, we developed a theranostic platform (CS@EAgNP) using TPP-modified chitosan to load silver sodium nitroprusside nano-aggregates (AgNP) and epigallocatechin gallate (EGCG). This system combines ultrasound (US) imaging with US-activated therapy. The CS@EAgNP nano-aggregates can act as an excellent US contrast enhancer. In vivo US imaging indicated that AgNP generated significantly enhanced echo signals at the infection site, providing real-time and high-contrast visualization of the inflammatory foci that was unattainable with normal lung tissue. Moreover, these nano-aggregates release NO, silver and EGCG under US. The NO and silver penetrate biofilms to kill MRSA, while EGCG scavenges reactive oxygen species and modulates inflammation. This reduces pro-inflammatory cytokines like IL-6 and TNF- α , mitigating the cytokine storm. In vivo results further confirm that this image-guided strategy achieves significant bacterial clearance and promotes lung tissue regeneration without detectable toxicity to major organs. This integrated approach bridges diagnosis and treatment, offering a promising solution for managing MRSA pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Examination, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou 510280, People's Republic of China.
- Department of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, People's Republic of China.
- School of Pharmacy, Guangdong Medical University, Dongguan 523808, People's Republic of China.
ORCID-Profile: Minxian Ji, Guanhai Wang
Förderung
- Key Laboratory of Polymeric Composite and Functional Materials of Ministry of Education
- GuangDong Basic and Applied Basic Research Foundation
Zitieren
APA
Ji, M., Li, G., Xie, L., & Wang, G. (2026). Silver sodium nitroprusside nano-aggregates for ultrasound-activated immunomodulatory therapy of MRSA pneumonia. Biomedical Materials. https://doi.org/10.1088/1748-605x/aeb215
Vancouver
Ji M, Li G, Xie L, Wang G. Silver sodium nitroprusside nano-aggregates for ultrasound-activated immunomodulatory therapy of MRSA pneumonia. Biomedical Materials. 2026. doi:10.1088/1748-605x/aeb215
BibTeX
@article{Ji2026,
author = {Ji, Minxian and Li, Guanxue and Xie, Lihua and Wang, Guanhai},
title = {Silver sodium nitroprusside nano-aggregates for ultrasound-activated immunomodulatory therapy of MRSA pneumonia},
journal = {Biomedical Materials},
year = {2026},
doi = {10.1088/1748-605x/aeb215}
}
EUVIMED